Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191007045013N1Phase 3Completed
Phase 3, randomised, double-blind trial in Nausea and Vomiting comparing Ondansetron arm with Granisetron arm (2 arms). Primary endpoint: Nausea and vomiting. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191007045013N1.